Cyclin-dependent kinase 2 (CDK2) is a key macromolecule in cell cycle regulation. In cancer cells, CDK2 is often overexpressed and its inhibition is an effective therapy of many cancers including breast carcinomas, leukemia, and lymphomas. Quantitative characterization of the interactions between CDK2 and its inhibitors at atomic level may provide a deep understanding of protein-inhibitor interactions and clues for more effective drug discovery. In this study, we have used the computational alanine scanning approach in combination with an efficient interaction entropy method to study the microscopic mechanism of binding between CDK2 and its 13 inhibitors. The total binding free energy from the method shows a correlation of 0.76−0.83 with the experimental values. The free energy component reveals two binding mode in the 13 complexes, namely van der Waals dominant, and electrostatic dominant. Decomposition of the total energy to per-residue contribution allows us to identify five hydrophobic residues as hot spots during the binding. Residues that are responsible for determining the strength of the binding were also analyzed.
I. INTRODUCTION
Cyclin-dependent kinases (CDKs), a family of 13 members including CDK1−CDK13 [1, 2] , are serinethreonine kinases that phosphorylate their substrates on serines and threonines. CDKs and cyclin along with their synergistic effects are important factors in the cell cycle regulation [3] . CDK2 is a member of CDKs and regulates cells cycle mainly by binding to cyclin E (FIG. 1) [4, 5] . It plays a vital role in regulating cell cycle, regulating transcription, mRNA processing, and the differentiation of nerve cells. Cyclin E-CDK2 complex plays a key role in the cell cycle from G1 to S phase [6−8] through phosphorylation and complete inactivation of the active site in the Retinoblastoma (RB) protein [9, 10] . Cyclin D-CDKs and cyclin E-CDK2 collaborate to make cells pass the restriction point [11] .
CDKs and cell cyclin are often overexpressed in cancer cells. Bing et al found that the dominant-negative constructs of CDK2 can halt cell cycle progression [12] . In the report of Du et al., CDK2 shows a very important role for human melanoma growth and proliferation. The CDK2-knockout melanoma cells lose the colony-forming activity, and are arrested in G1 phase [13] . Some researches show that cyclin E/CDK2 is overexpressed during the growth of hormone adenomas [14] . Therefore, CDK2 inhibitors are able to suppress the growth of cancer cells through directly perturbing the binding of CDKs and cyclins [15] . In the past few decades, CDK2 has become an important therapeutic target for cancer, and many inhibitors with diverse scaffolds have surfaced out [16, 17] . For example, a recently discovered inhibitor CCT068127 significantly reduces cell proliferation, effectively inhibits the phosphorylation of RB in human cancer cells, and thus induces cell cycle arrest and cell apoptosis [18] . However, no CDK2 inhibitor has been approved for therapeutic use so far.
Drug discovery and development is a time-consuming and resource-intensive process [19, 20] . Computational techniques are becoming increasingly important in drug design, development and optimization [21−23] . Binding free energy quantifies the binding strength of protein and ligand, and is closely related to the efficacy of the ligand. Various computational methods have been developed for calculating the binding energy, including physics-based methods [24] , empirical scoring functions [25] , knowledge-based potentials [26] , and descriptorbased scoring functions [27, 28] . In a recent research, we presents a reliable method named interaction entropy (IE) for calculating entropy [29] . Generally, only a few key residues (hot-spots) make significant contributions to the protein-ligand binding free energy. In this study, we combine the interaction entropy (IE) [29] and computational alanine scanning [30] (AS) method to identify key residues in the CDK2-inhibitor interaction by calculating the contribution of each pocket residue to the total binding free energy. The summation of the contributions from these hot-spots shows high correlation with the experimentally measured binding affinities.
II. MATERIALS AND METHODS

A. Alanine scanning for residue-specific binding free energies
In the alanine scanning method, a specific residue is mutated to alanine and the free energy difference before and after the mutation is computed (FIG. 2) . It is generally assumed that alanine contributes negligibly to the binding free energy. Thus, the difference of binding energy before and after mutation gives a quantitative measure of the contribution from the mutated residue. The free energy difference for mutating a specific residue x to a (alanine) is defined by In Eq.(2), the gas-phase component can be simplified by the approximation In Eq.(4), ∆G
x gas (x-L) represents the gas-phase component of the free energy generated by the interaction between residue x and ligand L, similarly for ∆G a gas (a − L). Eq. (4) is based on a standard alanine scanning method in which the configuration of all other residues (excluding the x residue) remains the same before and after the x residue is mutated to alanine. Thus, the gas-phase interaction energy between the ligand and the rest of all other residues is canceled out in Eq.(4).
We used the interaction entropy (IE) approach [29, 31−34] to calculate the gas-phase component in Eq.(4) [34] .
and similarly for the mutant
In Eq. (5) and (6), the E x int term is the energy between the residue x and the ligand, and the exponential term ∆E 
where N is the number of discrete MD time steps, and finally Eq. (4) gives
The GBSA method was used to calculate the solvation free energy, which is composed of polar and nonpolar components,
where the polar component ∆G gb is the electrostatic solvation free energy obtained by the generalized Born (GB) model and the non-polar component ∆G np is estimated by using the empirical solvent accessible surface (SASA) formula available in Amber 16 [35, 36] :
here the default values of 0.00542 kcal/(mol·Å 2 ) and 0.92 kcal/mol were used for the constant γ and β. Finally Eq. (3) Using the above methods, we can obtain the contribution of each pocket residue ∆∆G x→a bind , and the total protein-ligand binding free energy is derived with the following approximation
B. Molecular dynamics simulations
A total of 13 protein-ligand compounds that have experimental affinity data were used to calculate residuespecific binding free energies using the AS-IE method. The initial structures were derived from the proteinligand complex structures from the protein data bank (PDB) [37, 38] . MD simulations were performed using pmemd.cuda [39] with the ff99SB force field [40] in Amber 16 [35, 36] . All molecular dynamic simulations were performed in TIP3P explicit water with a periodic rectangular box. The distance from the edge of the box to the nearest solute atom was 10Å. Counter ions were added to maintain the neutrality of the system. Langevin thermostat was applied to control the temperature at 300 K, and time step was set at 2 fs. The steepest descent algorithm followed by the conjugate gradient method was first used to minimize the energy of hydrogen atoms and solvent molecules. The entire system was subsequently minimized without any restraints, and slowly heated from 0 K to 300 K, followed by 2-ns equilibration performed at a constant temperature of 300 K in an NPT ensemble. After equilibration, three independent 20-ns MD simulations were performed for each system, with 20000 frames evenly extracted from each MD trajectory. In addition, three independent simulations with the protein backbone restrained were also performed for each system. The 2.5-ns segment showing the most stable electrostatic (account for solvation) and van der Waals energies in each trajectory was selected for the binding free energy calculation (FIG. 3) .
III. RESULTS AND DISCUSSION
We applied the AS-IE method to calculate the binding free energies of a total of 13 CDK2-inhibitor complexes, whose binding affinities have been determined experimentally and the crystal structures are available in PDB (FIG. 4) . 
A. The effects of protein dielectric constant
The choice of protein's internal dielectric constant significantly affects the performance of the MM/GB(PB)SA method [31] . In our previous study of protein-protein binding, using different dielectric constants for different types of amino acids greatly improved the accuracy of the free energy calculation [31, 34, 41] . In our protein-ligand studies, a dielectric constant of 1, 3, 6, and 7, adopted from the protein-protein binding study, was used for nonpolar, polar, basic and acidic residues [42, 43] . In this study, we used the complex structure of CDK2-NU6094 (PDB ID: 1H1Q) [44] to benchmark five different sets of dielectric constant. As shown in Table I , the average ∆G with different dielectric constants is 17.05 kcal/mol, and the influence of different dielectric constant is marginal. However, the calculated energy is significantly larger than the experimental value (8.24 kcal/mol). In the following, we calculated the binding free energy with a dielectric constant of 1, 3, 5, and 5, for nonpolar, polar, basic, and acidic residue, respectively. 
B. Total binding free energy from ASIE
We then calculated the binding free energy of CDK2 and its 13 inhibitors using AS-IE and compared the results with those from the MM/GBSA and normal mode method. To examine the effects of trajectory stability on the results, we performed two simulations for each complex, one with restrains on the protein backbone atoms and another one without restrains. The Pearson correlation coefficient is 0.76 without restraints and 0.83 with backbone restraints using the AS-IE method (FIG. 5(a, b) ). This is because the restrained systems have smaller energy fluctuations and thus smaller errors in the entropy calculation using the exponential average in Eq. (5) and (6) . Notably, the enthalpy alone from conventional MM/GBSA calculation has a correlation of 0.73 (FIG. 5(c) ). When the entropic contribution is included on top of the MM/GBSA results using IE or normal mode, the correlation becomes 0.66 (FIG. 5(d) ) and 0.25 (FIG. 5(e) ), respectively. These results suggest that IE is a better method to compute the entropy, even with the conventional MM/GBSA method. Table II shows the details of the 13 complexes using different methods. The mean absolute error (MAE) between experimental and calculated values is the smallest when calculated using AS-IE without restraints during simulations. When the protein is restrained, both AS-IE and MM/GBSA show increase of free energy compared to that of the non-restrained systems. This increase is largely due to increased enthalpy from close interactions between the protein and ligand in the restrained system. As the restrained system shows better correlation that is more important in ranking different inhibitors, further analysis is based on the restrained system. Moreover, all computational results show an overestimation of the binding energy compared to experimental values, which is commonly observed in MM/GBSA-based calculations. We suspect such difference is largely due to neglect of the contribution from water molecules inaccuracy of the force field in the calculation. free energy. Table IV lists the detailed contribution of pocket residues in the 2CLX complex. The strong electrostatic interactions mostly come from two positively charged residues Lys33 and Lys89 (FIG. 6) . The other important pocket residues are V18 (∼2.91 kcal/mol), I10 (∼2.85 kcal/mol), L134 (∼2.41 kcal/mol), K89 (∼1.81 kcal/mol), F82 (∼1.36 kcal/mol), and K33 (∼1.03 kcal/mol). The electrostatic and solvation energy together is 9.44 kcal/mol and contributes 53% of the total binding free energy. The D145 residue has a negative charge and two hydrogen bonds with the compound. However, in our calculation, the contribution of this residue is only 0.16 kcal/mol. These results suggest that the AS-IE method can provide detailed quantitative profiles of the pocket residues that are not available in a static structure and reveal the binding mode of the inhibitor, which could be beneficial for further optimization of the compound. For other complex where van der Waals interactions dominate the protein-ligand interaction, we analyzed the 1H1Q complex as an example (Table V) . In this complex, the van der Waals provides more than 98% of the total binding enthalpy. The important pocket residues for 1H1Q are L134 (∼3.25 kcal/mol), I10 (∼3.01 kcal/mol), F82 (∼2.84 kcal/mol), V18 (∼1.51 kcal/mol), and L83 (∼1.14 kcal/mol). L134 has two Pi-alkyl interactions, with a distance of 3.2Å and 3.4Å (FIG. 6(b) ), and I10 has two Pi-Alkyl interactions with a distance of 4.2Å and 4.7Å respectively. The calculation result is in good agreement with CDK2-ligand FIG. 7(a) list the residues whose average contribution is more than 0.5 kcal/mol. Among them, five residues (L134, I10, F82, V18, F80) contribute more than 1 kcal/mol and are thus classified as hot-spots residues. The contributions of L134, I10 and F82 are much bigger than other residues. To better understand their roles in CDK2-inhibitor binding, the detailed contribution of L134 is shown in FIG. 7(b) . The contribution of L134 is 0.73−3.77 kcal/mol in 13 systems, and the contribution above 3 kcal/mol is more than 54% systems. So for most systems, the hot-spots play the key role in maintaining the CDK2-inhibitor stability, and the hot-spots like L134 is a stable binding free energy contributor.
C. Detailed breakdown of the binding energy
To identify the residues that are responsible for the strength of the CDK2-inhibitor interactions, we compared the residue contributions in four weakest (2EXM, 2CLX, 1E1V, 1JSV) and strongest complexes (1H1S, 4BCK, 2FVD, 1PXO) in FIG. 8. I10, L134, F82 , and F80 in total contribute ∼3.72 kcal/mol more energy in the strong-binding systems than that in the weakbinding systems. Considering that the average binding free energy difference in weak and strong system is 5.39 kcal/mol, these four residues account for 69% of the difference. A possible choice to further enhance the binding strength is to optimize the interaction to the residues that have similar energies in weak and strong systems, namely V18, K89, K33, and L83.
IV. CONCLUSION
In this study, we have used AS-IE to study the interactions between CDK2 and its inhibitors. The total binding free energy from ASIE shows good correlation with experimental values, revealing two binding modes in the 13 complexes, namely van der Waals dominant, and electrostatic dominant. Moreover, it is possible to derive the per-residue contribution and the detail energy component including electrostatic, van der Waals, solvation, and entropy. On the basis of the per-residue contribution, hot-spots residues and the residues responsible for the ligand binding strength were identified. Such quantitative decomposition of the binding free energy may provide insights on the binding mode of the inhibitors and clues on how to design new inhibitors.
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